Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FBU | Ann: Update to ASX Appendix 3A.1 (FX rate) | 27/03/19 | 0 | 22 | |||
|
|||||||
FBU | Ann: D&O Ongoing Disclosures - Multiple | 25/03/19 | 0 | 32 | |||
|
|||||||
FBU | Ann: ASX Appendix 3A.1 - Notification of Dividend | 20/02/19 | 0 | 133 | |||
|
|||||||
FBU | Ann: Fletcher Building Limited - 2019 Half Year Results | 20/02/19 | 0 | 115 | |||
|
|||||||
FBU | Ann: NZICC Update | 13/02/19 | 0 | 132 | |||
|
|||||||
FBU | Ann: Fletcher Building HY19 Results Webcast Details | 11/02/19 | 0 | 144 | |||
|
|||||||
FBU | Ann: SPH Notice - Perpetual Limited and subsidiaries | 01/02/19 | 0 | 116 | |||
|
|||||||
FBU | Ann: D&O Ongoing Disclosure - Claire Carroll | 07/01/19 | 0 | 164 | |||
|
See All Discussions